Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregory Bashian

Clinical Cardiac Electrophysiology Nashville, TN Medical Doctor

NPI 1487854311 CMS profile 339945

2400 Patterson St Ste 502, Nashville, TN 37203

Open in the dashboard

General payments

$360,889

611 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$174,895 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Gregory Bashian of Nashville, TN is reported in the CMS Open Payments database as having received $360,889 across 611 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $174,895 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,230 69
2024 General $8,343 76
2023 General $20,541 84
2022 General $104,866 133
2021 General $117,163 113
2020 General $58,702 69
2019 General $43,045 67

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Bashian
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Gregory Bashian were reported at $8,230. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Gregory Bashian Clinical Cardiac Electrophysiology median Middle half National median
2019 $43,045 $2,361 $585–$8,260 $163
2020 $58,702 $993 $247–$4,351 $114
2021 $117,163 $1,185 $326–$4,739 $132
2022 $104,866 $2,073 $554–$6,789 $149
2023 $20,541 $2,568 $759–$8,159 $160
2024 $8,343 $2,557 $703–$7,403 $164
2025 $8,230 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sanofi-Aventis U.S. LLC $242,370 145 payments
  2. Abbott Laboratories $46,359 90 payments
  3. Pfizer Inc. $35,369 59 payments
  4. E.R. Squibb & Sons, L.L.C. $23,186 19 payments
  5. Medtronic, Inc. $5,807 93 payments
  6. Boston Scientific Corporation $4,833 129 payments
  7. Biosense Webster, Inc. $1,066 8 payments
  8. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $379 16 payments
  9. Philips Electronics North America Corporation $223 4 payments
  10. Impulse Dynamics (USA) Inc. $174 1 payment
  11. Other $1,122 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $282,859 134 payments
  2. Consulting Fee $54,159 38 payments
  3. Food and Beverage $15,350 398 payments
  4. Travel and Lodging $8,468 38 payments
  5. Education $54 3 payments
Products named General payments · program years 2019–2025
  1. MULTAQ Cardiology/Vascular Diseases $149,906 89 payments
  2. MULTAQ Cardiology/Vascular Diseases $67,468 40 payments
  3. ELIQUIS Cardiovascular;Metabolic Disease $35,350 58 payments
  4. ENSITE PRECISION $25,255 41 payments
  5. ELIQUIS Cardiovascular $22,262 16 payments
  6. ADVISOR $7,870 2 payments
  7. TACTICATH ABLATION CATHETER, SENSOR ENABLED $6,762 7 payments
  8. Micra $4,725 49 payments
  9. MULTAQ Cardiovascular $4,412 7 payments
  10. ENSITE $3,363 10 payments
  11. Other $14,457 285 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 23 drugs

Part D claims

1,564

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$764,341

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

61.1%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 494 $558,809
Xarelto Rivaroxaban Brand 81 $96,376
Multaq Dronedarone Hcl Brand 63 $81,991
Metoprolol Succinate Generic 246 $5,127
Amiodarone Hcl Generic 133 $3,743
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 79 $3,116
Diltiazem 12hr Er Diltiazem Hcl Brand 21 $3,056
Dabigatran Etexilate Dabigatran Etexilate Mesylate Brand 12 $2,638
Mexiletine Hcl Generic 13 $2,145
Sotalol Sotalol Hcl Brand 85 $1,982

The 10 drugs with the highest cost, of 23 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$351,075

Medicare's payments for the services billed

Medicare patients

794

Average age 77

Services billed

6,382

305 women, 489 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 71%
Ischemic heart disease 57%
Arthritis 50%
Heart failure 48%
Diabetes 38%
Chronic kidney disease 37%
Depression 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • PFIZER INC. $73
$73 494 —
MULTAQ
  • SANOFI-AVENTIS U.S. LLC $66
$66 63 —
NURTEC ODT
  • PFIZER INC. $63
$63 — —
PAXLOVID
  • PFIZER INC. $44
$44 — —
Arcalyst
  • Kiniksa Pharmaceuticals International, plc $38
$38 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

611 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record